Zyversa Therapeutics Inc
ZVSA0.311USD
-0.238-43.30%
交易中 （美东）报价延迟15分钟
USD0.000盘前交易 (美东)
799.48K总市值
亏损市盈率 TTM
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
营业费用
-24.13%2.14M
-27.57%1.29M
-21.81%2.27M
-46.52%2.75M
-38.45%2.83M
-65.75%1.78M
-14.51%2.90M
173.43%5.15M
36.33%4.59M
191.92%5.19M
60.57%3.40M
1.77%1.88M
71.61%3.37M
--1.78M
--2.11M
--1.85M
--1.96M
研发费用
-49.53%258.88K
-52.84%121.25K
-35.30%436.04K
-41.91%709.05K
-51.42%512.94K
-84.76%257.11K
-71.13%673.94K
69.67%1.22M
-1.03%1.06M
166.15%1.69M
473.57%2.33M
44.89%719.39K
81.81%1.07M
--633.97K
--406.95K
--496.51K
--586.85K
折旧摊销及损耗
-100.00%0.00
-100.00%0.00
-33.35%1.73K
0.00%2.60K
0.00%2.60K
0.00%2.60K
0.00%2.60K
0.00%2.60K
0.00%2.60K
0.00%2.60K
0.00%2.60K
0.00%2.60K
0.00%2.60K
--2.60K
--2.60K
--2.60K
--2.60K
营业利润
24.13%-2.14M
27.57%-1.29M
21.81%-2.27M
46.52%-2.75M
38.45%-2.83M
65.75%-1.78M
14.51%-2.90M
-173.43%-5.15M
-36.33%-4.59M
-191.92%-5.19M
-60.57%-3.40M
-1.77%-1.88M
-71.61%-3.37M
---1.78M
---2.11M
---1.85M
---1.96M
净非营业利息收入（费用）
利息费用
----
----
----
----
----
----
----
----
----
-75.71%49.72K
-69.24%69.35K
-36.57%140.40K
-1.03%168.06K
--204.72K
--225.49K
--221.34K
--169.82K
特殊收入（费用）
--7.20K
----
----
----
----
-6422.63%-12.16M
100.00%0.00
-414259.20%-81.18M
----
-1627.88%-186.40K
-149.59%-228.10K
184.85%19.60K
-2725.36%-212.10K
--12.20K
--459.99K
---23.10K
---7.51K
税前利润
20.16%-2.26M
89.78%-1.42M
17.28%-2.40M
96.81%-2.75M
38.43%-2.83M
-156.98%-13.93M
21.39%-2.90M
-4207.19%-86.33M
-22.48%-4.59M
-175.37%-5.42M
-96.43%-3.69M
4.34%-2.00M
-75.15%-3.75M
---1.97M
---1.88M
---2.10M
---2.14M
所得税
----
99.50%-2.96K
100.00%0.00
100.12%9.71K
100.00%0.00
20.00%-596.07K
---485.00
---7.81M
---1.05M
---745.05K
----
----
----
----
----
----
----
除税后利润
20.16%-2.26M
89.34%-1.42M
17.27%-2.40M
96.48%-2.76M
20.24%-2.83M
-185.18%-13.34M
21.40%-2.90M
-3817.40%-78.51M
5.46%-3.54M
-137.53%-4.68M
-96.43%-3.69M
4.34%-2.00M
-75.15%-3.75M
---1.97M
---1.88M
---2.10M
---2.14M
持续经营利润
20.16%-2.26M
89.34%-1.42M
17.27%-2.40M
96.48%-2.76M
20.24%-2.83M
-185.18%-13.34M
21.40%-2.90M
-3817.40%-78.51M
5.46%-3.54M
-137.53%-4.68M
-96.43%-3.69M
4.34%-2.00M
-75.15%-3.75M
---1.97M
---1.88M
---2.10M
---2.14M
归属于母公司的净利润
20.16%-2.26M
89.34%-1.42M
18.18%-2.40M
96.80%-2.76M
20.24%-2.83M
-185.18%-13.34M
78.06%-2.93M
-3600.80%-86.43M
5.46%-3.54M
-137.53%-4.68M
-611.59%-13.38M
-11.47%-2.34M
-75.15%-3.75M
---1.97M
---1.88M
---2.10M
---2.14M
优先股派息
----
----
----
----
----
--0.00
-99.67%32.37K
2290.05%7.92M
----
--0.00
--9.68M
--331.20K
----
--0.00
--0.00
--0.00
----
归属于普通股东的净利润
20.16%-2.26M
89.34%-1.42M
18.18%-2.40M
96.80%-2.76M
20.24%-2.83M
-185.18%-13.34M
78.06%-2.93M
-3600.80%-86.43M
5.46%-3.54M
-137.53%-4.68M
-611.59%-13.38M
-11.47%-2.34M
-75.15%-3.75M
---1.97M
---1.88M
---2.10M
---2.14M
基本每股收益
83.97%-0.73
98.80%-0.71
92.67%-2.43
99.80%-3.31
96.66%-4.53
66.45%-59.63
93.48%-33.16
-1809.27%-1.69K
4.59%-135.88
-137.53%-177.71
-611.60%-508.26
-11.47%-88.73
-75.15%-142.42
---74.82
---71.42
---79.60
---81.31
稀释每股收益
83.97%-0.73
98.80%-0.71
92.67%-2.43
99.80%-3.31
96.66%-4.53
66.45%-59.63
93.48%-33.16
-1809.27%-1.69K
4.59%-135.88
-137.53%-177.71
-611.60%-508.26
-11.47%-88.73
-75.15%-142.42
---74.82
---71.42
---79.60
---81.31
每股派息
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
货币单位
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
审计意见
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
